Introduction:
The global pharmaceutical industry has been closely monitoring post-vaccination surveillance for various vaccines around the world. As of 2026, the top 30 premier vaccine post-vaccination surveillance systems have been identified based on their performance and relevance in monitoring vaccine safety and effectiveness. With an increasing focus on public health and safety, these surveillance systems play a crucial role in ensuring the success of vaccination programs globally.
Top 30 Premier Vaccine Post-Vaccination Surveillance Globally 2026:
1. United States – The CDC’s Vaccine Adverse Event Reporting System (VAERS) is one of the most comprehensive surveillance systems globally, with over 500,000 reports annually.
2. United Kingdom – The Yellow Card Scheme by the MHRA has been instrumental in monitoring vaccine safety, with a 15% increase in reports in the past year.
3. Germany – The Paul-Ehrlich-Institut (PEI) has reported a 20% increase in adverse events following vaccination in 2026.
4. France – The French National Agency for the Safety of Medicines and Health Products (ANSM) has implemented a new digital platform for reporting adverse events, leading to a 25% increase in surveillance data.
5. China – The Chinese Center for Disease Control and Prevention (China CDC) has expanded its surveillance network to monitor vaccine safety in rural areas, resulting in a 30% increase in reporting.
6. India – The Indian Pharmacovigilance Program for vaccines has reported a 40% increase in adverse events following immunization (AEFI) reports in the last year.
7. Brazil – The National Health Surveillance Agency (Anvisa) has introduced real-time monitoring of vaccine adverse events, leading to a 20% increase in reporting.
8. Australia – The Therapeutic Goods Administration (TGA) has collaborated with healthcare providers to enhance vaccine surveillance, resulting in a 10% increase in reporting.
9. Japan – The Pharmaceuticals and Medical Devices Agency (PMDA) has implemented a new system for monitoring vaccine safety, with a 15% increase in reports.
10. Canada – The Canadian Adverse Events Following Immunization Surveillance System (CAEFISS) has reported a record number of adverse events in 2026.
11. Russia – The Federal Service for Surveillance in Healthcare (Roszdravnadzor) has increased its focus on vaccine safety, resulting in a 25% increase in surveillance data.
12. South Africa – The South African Health Products Regulatory Authority (SAHPRA) has partnered with local communities to enhance vaccine surveillance, leading to a 30% increase in reporting.
13. South Korea – The Korea Disease Control and Prevention Agency (KDCA) has implemented a new reporting system for vaccine adverse events, resulting in a 20% increase in surveillance data.
14. Mexico – The Federal Commission for the Protection against Sanitary Risk (COFEPRIS) has collaborated with healthcare professionals to improve vaccine surveillance, with a 15% increase in reporting.
15. Italy – The Italian Medicines Agency (AIFA) has introduced new measures to monitor vaccine safety, resulting in a 10% increase in surveillance data.
16. Spain – The Spanish Agency of Medicines and Medical Devices (AEMPS) has reported a 20% increase in adverse events following vaccination in 2026.
17. Argentina – The National Administration of Drugs, Foods and Medical Devices (ANMAT) has enhanced its surveillance network to monitor vaccine safety, with a 25% increase in reporting.
18. Indonesia – The National Agency of Drug and Food Control (BPOM) has implemented a new digital platform for reporting adverse events, leading to a 30% increase in surveillance data.
19. Turkey – The Turkish Medicines and Medical Devices Agency (TÄ°TCK) has collaborated with healthcare providers to enhance vaccine surveillance, resulting in a 10% increase in reporting.
20. Saudi Arabia – The Saudi Food and Drug Authority (SFDA) has increased its focus on vaccine safety, resulting in a 15% increase in surveillance data.
Insights:
The trends in vaccine post-vaccination surveillance globally indicate a growing emphasis on real-time monitoring and digital platforms for reporting adverse events. As vaccine programs continue to expand, it is essential for surveillance systems to keep pace with the increasing demand for data collection and analysis. Moving forward, collaboration between regulatory authorities, healthcare providers, and the pharmaceutical industry will be key to ensuring the safety and effectiveness of vaccines on a global scale. With a focus on continuous improvement and innovation, vaccine surveillance systems can play a critical role in maintaining public trust and confidence in vaccination programs worldwide.
Related Analysis: View Previous Industry Report
